Header Logo

Connection

ANDREW SHER to Cytotoxicity, Immunologic

Back to Details
This is a "connection" page, showing publications ANDREW SHER has written about Cytotoxicity, Immunologic.
ANDREW SHER
Connection Strength
0.048
Cytotoxicity, Immunologic
  1. Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results. Nat Med. 2023 Jun; 29(6):1379-1388.
    View in: PubMed
    Score: 0.048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.